Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance. by Emily E Evans, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze, Maia Kipiani, Shorena Sabanadze, Alison G C Smith, Zaza Avaliani, Jeffrey M Collins, Russell R Kempker

Get full text

Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. by Jeffrey M Collins, Maia Kipiani, Yutong Jin, Ashish A Sharma, Jeffrey A Tomalka, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze, Shorena Sabanadze, Zaza Avaliani, Henry M Blumberg, David Benkeser, Dean P Jones, Charles Peloquin, Russell R Kempker

Get full text

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis by Linda J. Harrison, Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric Nuermberger, Susan E. Dorman, Elisa Ignatius, Janeway Granche, Patrick P. J. Phillips, Jennifer Furin, Eunsol Yang, Colleen Foley, Shawn Chiambah, Rochelle Rogers, Austin Van Grack, Jhoanna Roa, Justin Shenje, Sandy Nerette, Cecilia Kanyama, Rachel Bakyayita Kyeyune, Alberto Mendoza-Ticona, William Murtaugh, Salah Foraida, Melanie Goth, Andrew Vernon, Kelly E. Dooley, Radojka M. Savic

Get full text